Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1110.88x is in line with its 3-year average of -1220.48x, around the middle of its 3-year range (-1545.69x–-186.21x).
5.15% below its 12-month average of -1056.48x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -969.11x.
INTEREST COVERAGE RATIO
-1110.88x
INTEREST COVERAGE RATIO AVG TTM
-1056.48x
INTEREST COVERAGE RATIO AVG 3Y
-1220.48x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.15%
CURRENT VS 3Y AVG
+8.98%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 292 covered companies
CURRENT VS SECTOR MEDIAN
-37240.50%
vs the sector median at left
Actuate Therapeutics Inc
Market Cap
$20.93M
Interest Coverage Ratio
-1110.88x
TTM Avg
-1056.48x
3Y Avg
-1220.48x
5Y Avg
N/A
Market Cap
$21.90M
Interest Coverage Ratio
4.39x
TTM Avg
4.39x
3Y Avg
4.39x
5Y Avg
4.39x
Market Cap
$18.82M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$18.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.44M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.58M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.54M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$25.48M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $20.93M | -1110.88x | -1056.48x | -1220.48x | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 4.39x | 4.39x | 4.39x | 4.39x |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -6.31x | 0.97x | 0.97x | 0.97x |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | N/A | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -111.88x | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -15.67x | 0.81x | 0.81x | 0.81x |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -17.20x | 55.75x | 55.75x | 55.75x |
| BioCardia, Inc. (BCDA)vs › | $16.22M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -68.14x | N/A | N/A | N/A |
Interest Coverage
-1110.9x
Debt/Equity
0.41
Current Ratio
1.25
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -969.11x |
| 2026-03-31 | -1127.21x |
| 2025-12-31 | -926.05x |
| 2025-09-30 | -1080.86x |
| 2025-06-30 | -1179.15x |
| 2025-03-31 | -1257.28x |
| 2024-12-31 | -1292.18x |
| 2024-09-30 | -1545.69x |
| 2024-06-30 | -1070.81x |
| 2024-03-31 | -1531.37x |
| 2023-12-31 | -1504.08x |
| 2023-09-30 | -1279.27x |
| 2023-06-30 | -1103.20x |
| 2023-03-31 | -186.21x |
